LLY
715.06
-1.34%↓
JNJ
152.52
-0.44%↓
ABBV
182.34
+0.35%↑
NVO
68.13
-0.07%↓
UNH
296.46
-2.25%↓
LLY
715.06
-1.34%↓
JNJ
152.52
-0.44%↓
ABBV
182.34
+0.35%↑
NVO
68.13
-0.07%↓
UNH
296.46
-2.25%↓
LLY
715.06
-1.34%↓
JNJ
152.52
-0.44%↓
ABBV
182.34
+0.35%↑
NVO
68.13
-0.07%↓
UNH
296.46
-2.25%↓
LLY
715.06
-1.34%↓
JNJ
152.52
-0.44%↓
ABBV
182.34
+0.35%↑
NVO
68.13
-0.07%↓
UNH
296.46
-2.25%↓
LLY
715.06
-1.34%↓
JNJ
152.52
-0.44%↓
ABBV
182.34
+0.35%↑
NVO
68.13
-0.07%↓
UNH
296.46
-2.25%↓
24h
Actual
Mínimo
1.66
Máximo
1.72
Recomendaciones | Comprar |
---|---|
Estimación a 12 Meses | +488.24% upside |
Próximas Ganancias | 11 ago 2025 |
---|
Resultados pasados no son un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 Meses
Media 10 USD 488.24%
Máximo 16 USD
Mínimo 4 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$